Cloning of gag gene of HIV-1 subtype (Indian strain) into a mammalian expression vector and in vitro expression studies

Indian Journal of Medical Microbiology

Volumn 21, Issue 2, 2003, Pages 77-81

  Chugh, P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

DNA vaccine; gag; HIV 1 subtype C

Indexed keywords

ANTIGEN; ANTIGEN P24; CYTOKINE; DNA; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROTEINASE; RECOMBINANT PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; IMMUNOGENICITY; IN VITRO STUDY; MAMMAL; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SUPERNATANT; TRANSMISSION ELECTRON MICROSCOPY; VIRUS STRAIN; WESTERN BLOTTING;

EID: 0041919770     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Piot P, Bartos M, Ghys PD, Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature 2001;410(6831):968-73.
2. Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS. One world, one hope: the cost of providing antiretroviral therapy to all nations. AIDS 1998;12:2203-2209.
3. Nabel GJ. Challenges and opportunities for development of an AIDS vaccine. Nature 2001;410(6831):1002-7.
4. Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka GR, Beaudry K, Lifton MA, Nickerson CE, Trigona WL, Punt K, Freed DC, Guan L, Dubey S, Casimiro D, Simon A, Davies ME, Chastain M, Strom TB, Gelman RS, Montefiori DC, Lewis MG. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000;290(5491):486-92.
5. Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney, Weiner DB. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997;3(5):526-32.
6. Paliard X, Liu Y, Wagner R, Wolf H, Baenziger J, Walker CM. Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS Res Hum Retroviruses 2000;16(3): 273-82.
7. Deml L, Schirmbeck R, Reimann J. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies. Virology 1997;235(1):26-39.
8. Qiu JT, Liu B, Tian C, Pavlakis GN, Yu XF. Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway. J Virol 2000; 74(13):5997-6005.
9. Rowland-Jones SL, McMichael A. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol 1995; 7(4):448-55.
10. Nakamura Y, Kameoka M, Tobiume M, Kaya M, Ohki K, Yamada T, Ikuta K. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein. Vaccine 1997; 15(5):489-96.
11. Arora A, Fahey JL, Seth P. DNA vaccine for the induction of immune responses against HIV-1 subtype C envelope gene in mice. Gene Ther Mol Biol 2001;6:79-89.
12. Gheysen D, Jacobs E, de Foresta F, Thiriart C, Francotte M, Thines D, De Wilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 1989;59(1):103-12.